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Abstract
Background: To determine if adults with incident accelerated knee osteoarthritis (KOA) are more likely to have
degenerative knee ligaments or tendons compared to individuals with typical or no KOA.
Methods: We identified 3 sex-matched groups among Osteoarthritis Initiative participants who had a knee without
radiographic KOA at baseline (Kellgren-Lawrence [KL] < 2): 1) accelerated KOA: at least 1 knee had KL grade ≥ 3 in
≤48 months, 2) typical KOA: at least 1 knee increased in radiographic scoring within 48 months, 3) no KOA: both
knees had the same KL grade at baseline and 48 months. We evaluated knee magnetic resonance images up to 2
years before and after a visit when the accelerated or typical KOA criteria were met (index visit). Radiologists
reported degenerative signal changes for cruciate and collateral ligaments, and extensor mechanism and proximal
gastrocnemius tendons. We used generalized linear mixed models with 2 independent variables: group and time.
Results: Starting at least 2 years before onset, adults with accelerated KOA were twice as likely to have
degenerative cruciate ligaments than no KOA (odds ratio = 2.10, 95% CI = 1.18, 3.74). A weaker association (not
statistically significant) was detected for adults with accelerated versus typical KOA (OR = 1.72, 95%CI = 0.99, 3.02).
Regardless of time, adults with accelerated (odds ratio = 2.13) or typical KOA (odds ratio = 2.16) were twice as likely
to have a degenerative extensor mechanism than no KOA. No other structural features were statistically significant.
Conclusions: Degenerative cruciate ligaments or extensor mechanism antedate radiographic onset of accelerated
KOA. Hence, knee instability may precede accelerated KOA, which might help identify patients at high-risk for
accelerated KOA and novel prevention strategies.
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Background
While knee osteoarthritis (KOA) is characteristically a
slow progressing disorder, there is a subset of individuals
that experience an abrupt and accelerated onset of
radiographic advanced-stage disease, often less than 12
months [1–3]. Individuals that develop accelerated KOA
report greater knee symptoms and functional limitations
than those that develop the more common and gradual
onset of KOA as early as 3 years before radiographic dis-
ease onset [2]. Additionally, those with accelerated KOA
are 25 times more likely to receive a knee replacement
over 9 years than those with a gradual onset of KOA [4].
Furthermore, the median time from the first evidence of
radiographic progression to knee replacement is only
2.3 years, which highlights the short window for tertiary
prevention [4]. It is critical that we understand the
pathogenesis of accelerated KOA to develop strategies to
identify high-risk patients, those with early-stage (pre-
radiographic) accelerated KOA, and novel prevention
strategies.
Degeneration of knee tendons and ligaments may
antedate the onset of radiographic accelerated KOA and
contribute to prodromal joint symptoms that are com-
mon to accelerated KOA. Degeneration of the cruciate
ligaments are present in knees with KOA and may
antedate KOA [5, 6]. Early degeneration of ligaments
and tendons may be a sign of abnormal joint loading or
instability, which increases shear force to the articular
cartilage, may be an early sign of a person at risk for
OA, and a risk factor for a knee injury that could
precipitate accelerated KOA [7]. However, it remains
unclear if the degenerative status of the ligaments and
tendons in the knee are associated with the development
of accelerated KOA.
We aimed to determine if incident accelerated KOA is
preceded and characterized by the degeneration of cruci-
ate or collateral ligaments, as well as extensor mechan-
ism or proximal gastrocnemius tendons compared to
those with no KOA or a gradual onset of KOA (typical
KOA). The Osteoarthritis Initiative (OAI) offers a
unique opportunity to study the relationship between
degeneration of ligaments and tendons and the natural
history of incident KOA, including accelerated KOA. If
people with accelerated KOA exhibit unique degenera-
tive ligament or tendon characteristics leading to the
onset of disease, it may indicate accelerated KOA is
preceded by maladaptive responses to overloading or
instability. If so, this may help identify high-risk patients
and novel prevention strategies.
MethodS
We conducted a longitudinal analysis of individuals in
the Osteoarthritis Initiative (OAI) using radiographs,
magnetic resonance (MR) images, and clinical data at
baseline and the first 4 annual follow-up visits. The OAI
is a multicenter cohort study of 4796 adults with or at
risk for symptomatic KOA. Staff at four clinical sites
(Memorial Hospital of Rhode Island, University of Mary-
land and Johns Hopkins University, the University of
Pittsburgh, and The Ohio State University) recruited
participants between 2004 and 2006. OAI data (includ-
ing images) and protocols are publicly available [8]. The
OAI has met all criteria for ethical standards regarding
human studies as described in the 1964 Declaration of
Helsinki and all amendments. The OAI study was
reviewed and approved by institutional review boards at
each OAI clinical site and the OAI coordinating center
(Memorial Hospital of Rhode Island Institutional Review
Board, University of Maryland Baltimore – Institutional
Review Board, University of Pittsburgh Institutional Re-
view Board, and The Ohio State University’s Biomedical
Sciences Institutional Review Board; Committee on Hu-
man Research at University of California, San Francisco;
Approval Number: 10–00532). All participants offered
written informed consent before starting the study.
Participant selection
We classified 3 groups based on radiographic criteria.
Adults with incident accelerated KOA included anyone
with at least 1 knee that had no radiographic KOA at
baseline (Kellgren-Lawrence [KL] grade < 2) that devel-
oped advanced-stage KOA (KL grade 3 or 4) within 48
months (n = 125) [3, 9]. Individuals with typical KOA
had no baseline radiographic KOA (KL < 2) in both
knees and 1 or more knee increased in radiographic
scoring within 48 months (n = 187; excluding those with
accelerated KOA). Individuals with no KOA had no
radiographic KOA in both knees at baseline and had no
change in KL grade in either knee during 48-months
(n = 1325).
Our overall goal of the accelerated KOA project was
to characterize accelerated KOA using imaging and
biochemical biomarkers as well as an array of clinical
outcomes (e.g., patient-reported outcomes, functional
assessments). Hence, to ensure the feasibility of complet-
ing all of the biomarker assessments we did 1:1:1 match-
ing based on sex (n = 125 participants/group).
Index knee
For adults with incident accelerated or typical KOA, the
index knee was the first knee to experience accelerated
or typical KOA, respectively. For an individual with no
KOA, we defined the index knee to be the same side as
their matched member of the accelerated KOA group.
Definition of index visit
For individuals with accelerated KOA, the index visit
was the OAI visit when a participant met the criteria for
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accelerated KOA (i.e., visit when someone had KL = 3 or
4; potential OAI visits: 12-, 24-, 36-, or 48-month visit).
For adults with typical KOA, the index visit was the OAI
visit when a participant met the criteria for typical KOA
(i.e., visit when someone first increased KL grade; poten-
tial OAI visits: 12-, 24-, 36-, or 48-month visit). For
someone with no KOA, the index visit was the same
OAI visit as that person’s matched member of the inci-
dent accelerated KOA group. Figure 1 illustrates exam-
ples of the index visit and observation period for a
member of each group.
Knee radiographs
To classify individuals into groups we relied on readings
of bilateral weight-bearing, fixed-flexion posteroanterior
knee radiographs. These images were obtained at base-
line and annual follow-up visits. Blinded central readers
recorded KL grades (0 to 4; weighted kappa = 0.70–0.80;
files: kXR_SQ_BU##_SAS; file versions: 0.6, 1.6, 3.5, 5.5,
and 6.3) [8].
Magnetic resonance imaging
Magnetic resonance (MR) images were attained annually
with one of four identical Siemens (Erlangen, Germany)
Trio 3-Tesla MR systems at each OAI site. The muscu-
loskeletal radiologists (RJW and JWM) performing semi-
quantitative scoring were provided all the sequences
acquired on each index knee at each visit; including a
sagittal intermediate-weighted, turbo spin echo, fat-
suppressed MR sequence with the following parameters:
field of view = 160mm, slice thickness = 3 mm, skip = 0
mm, flip angle = 180 degrees, echo time = 30ms, recov-
ery time = 3200 ms, 313 × 448 matrix, x resolution =
0.357 mm, y resolution = 0.511 mm, and total slice
number = 37. The OAI sequences have been described
elsewhere [8, 10].
MR image readings
Two musculoskeletal radiologists reviewed MR images
(RJW:255 cases, JWM:120 cases) to assess the integrity
of the anterior and posterior cruciate ligaments, medial
and lateral collateral ligaments, extensor mechanism
(quadriceps femoris tendon and patellar ligament) [11],
and gastrocnemius proximal tendons. Readers noted if
the structures appeared normal or had degenerative
pathologic findings. We defined a degenerative appear-
ance as the existence of atypical intrinsic high-signal
intensity in the substance of the ligaments or tendon
without a discrete tear. Readers had good agreement
among 25 cases: prevalence-adjusted and bias-adjusted
kappa (PABAK) were 0.42 to 0.75: anterior cruciate
ligament PABAK = 0.50, posterior cruciate ligament
PABAK = 0.48, medial collateral ligament PABAK = 0.75,
lateral collateral ligament PABAK = 0.67, extensor mech-
anism PABAK = 0.42, gastrocnemius proximal tendons
PABAK = 0.42.
Since less than 10% of adults with no KOA (n < 6) had
degeneration in the posterior cruciate ligament we ana-
lyzed the cruciate ligaments collectively as one outcome:
cruciate ligament degeneration, which was defined as
Fig. 1 Examples of the Index Visit and Observation Period for a Member of Each Group. Key abbreviations: Accelerated Knee Osteoarthritis
(AKOA), Knee Osteoarthritis (KOA), or No KOA. Kellgren-Lawrence (KL), Osteoarthritis Initiative (OAI). The red font represents the index visit (visit
relative to index = 0). For individuals with accelerated or typical KOA, the index visit was the OAI visit when a person met the criteria for
accelerated or typical KOA, respectively. * For someone with no KOA, the index visit was the same visit as that person’s matched member of the
incident accelerated KOA group. The observation period was up to 2 years before and after the index visit (visit relative to index = −2 to 2 years)
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the presence of degenerative appearance in the anterior
or posterior cruciate ligament. Similarly, less than 10%
of adults with no KOA (n < 3) had degeneration in the
lateral collateral ligament; hence, we analyzed the collat-
eral ligaments collectively as one outcome: collateral
ligament degeneration, which was defined as the pres-
ence of degenerative appearance in the medial or lateral
collateral ligament.
Statistical analysis
We ran descriptive statistics to assess baseline character-
istics of the 3 groups. To determine any association
between degeneration of the ligaments or tendons and
group assignment, we used generalized linear mixed
models assuming compound symmetry. Independent
variables included group (3 levels), and time (up to 5
levels). We also assessed a group-by-time interaction.
For our primary analyses we adjusted for sex (matching
variable) [12] and factors associated with missing MR
data at the next visit (i.e., age, body mass index, injury,
frequent knee pain, days with limited activity in prior
month, overall global rating, and WOMAC pain).
We conducted several sensitivity analyses: 1) adjusted
only for sex, which was our matching factor, 2) among
people who developed accelerated KOA and had no
radiographic OA bilaterally at baseline (n = 54 per group
with matched sample), 3) among individuals who devel-
oped accelerated KOA in < 12months (n = 71 per group
with matched sample), and 4) among those who devel-
oped typical KOA and had KL = 2, which is a common
radiographic criteria for KOA (n = 76 per group with
matched sample). We also performed one sensitivity
analysis with no matching among people with complete
data at every visit (accelerated KOA n = 12, typical KOA
n = 29, no KOA n = 25). Since the sensitivity analyses
were always among a smaller sample size, we performed
them adjusted for sex only. All analyses were conducted
with SAS Enterprise 7.15 (Cary, NC, USA).
Results
Descriptive characteristics
Table 1 offers an overview of the characteristics of the
three groups. In brief, the groups were mostly female
(63%), overweight, and 24 to 39% of participants in each
group reported frequent knee pain during the prior 12
months.
Table 2 highlights the frequency of the degenerative
ligaments and tendons over time.
We detected a significant group effect – but no group-
by-time interaction – for the presence of degenerative
cruciate ligaments (group p = 0.03; interaction p = 0.24)
and degenerative extensor mechanism (group p = 0.01;
interaction p = 0.43). We observed no significant associ-
ations with group nor group-by-time interaction with
the presence of degenerative collateral ligaments (group
p = 0.43; interaction p = 0.06) and proximal gastrocne-
mius tendon degeneration (group p = 0.71; interaction
p = 0.12).
Starting at 2 years prior to the index visit, the presence
of degenerative cruciate ligaments was stable over time:
ranging from 43 to 51% among those with accelerated
KOA, 22 to 33% among those with typical KOA, and 21
to 26% among people with no KOA. Regardless of time,
adults with accelerated KOA were twice as likely to have
degenerative cruciate ligaments than those with no KOA
(odds ratio [OR] = 2.10, 95% confidence interval [CI] =
1.18 to 3.74). We found a weaker association, which was
not statistically significant, for those with accelerated
KOA versus those with typical KOA (OR = 1.73, 95%
CI = 0.99 to 3.02). Adults with typical KOA had a similar
odds of having a degenerative cruciate ligament as those
with no KOA (OR = 1.21, 95% CI = 0.68 to 2.17). The
sensitivity analyses supported an association between
degenerative cruciate ligaments and accelerated KOA
(accelerated KOA vs No KOA OR range: 2.59 to 6.28;
accelerated KOA vs typical KOA OR range: 1.68 to 5.38)
with the highest OR among participants with complete
data. Similarly, the sensitivity analyses typically
Table 1 Descriptive Characteristics of those with Accelerated, Common, and No Knee Osteoarthritis (KOA) at Baseline
Variables
(means, SD; except where noted)
AKOA
(n = 125)
Typical KOA
(n = 125)
No KOA
(n = 125)
Females (n, %) 79 (63%) 79 (63%) 79 (63%)
Index knee KL Grade = 0 (n, %) 42 (34%) 71 (57%) 92 (74%)
Patellofemoral Osteoarthritis (MR-based) 88 (75%) 84 (69%) 80 (66%)
Frequent knee pain in past 12 months (n, %) 44 (35%) 49 (39%) 30 (24%)
Age (years) 62.5 (8.5) 58.4 (8.4) 57.3 (8.2)
Body mass index (kg/m2) 29.7 (4.6) 28.1 (4.4) 26.9 (4.4)
Global impact rating (0 to 10; higher score = greater impact) 1.7 (1.9) 1.1 (1.5) 0.8 (1.1)
How many days limited activities in past 30 days (0 to 30)? 3.2 (7.3) 1.7 (4.8) 1.4 (4.3)
WOMAC pain (0 to 20; higher score =more pain) 2.3 (3.1) 1.8 (2.3) 1.6 (2.4)
AKOA accelerated knee osteoarthritis, KL Kellgren-Lawrence, MR magnetic resonance, WOMAC Western Ontario and McMaster Universities Osteoarthritis Index
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supported the finding that degenerative cruciate liga-
ments had a weak or no association with typical KOA
(typical KOA vs No KOA OR range: 0.66 to 1.22) with
the exception of a potential association among those
who developed typical KOA with KL = 2 (OR = 1.85, 95%
CI = 0.88 to 3.92).
Starting at 2 years prior to the index visit, the presence
of degenerative extensor mechanism was stable over
time: ranging from 31 to 43% among those with acceler-
ated KOA, 39 to 42% among those with typical KOA,
and 22 to 32% among people with no KOA. Regardless
of time, adults with accelerated or typical KOA were
twice as likely to have degenerative extensor mechanism
than those with no KOA (accelerated KOA vs no KOA
OR = 2.13, 95% CI = 1.19 to 3.82; typical KOA vs no
KOA OR = 2.16, 95% CI = 1.23 to 3.79). Neither people
with accelerated nor typical KOA were more likely to
have a degenerative extensor mechanism than their
peers (accelerated vs typical KOA OR = 0.99, 95% CI =
0.57 to 1.70). The sensitivity analyses showed similar re-
sults (OR accelerated KOA vs No KOA OR range: 1.37
to 2.88; typical KOA vs No KOA OR range: 1.32 to 2.92;
accelerated KOA vs typical KOA OR range: 0.99 to 1.50)
.
Discussion
Adults with incident KOA (accelerated or typical KOA)
were more likely to have a degenerative extensor mech-
anism than those with no KOA. Furthermore, adults
with accelerated KOA were more likely to present with
degenerative cruciate ligaments than those with no
KOA, regardless of time. The degenerative changes were
evident at least 2 years prior to meeting the criteria for
incident disease and remained stable over time. Hence,
these changes may be early signs that can extend our
understanding of the pathogenesis of KOA, especially
accelerated KOA. These findings may offer novel in-
sights to recognize adults at-risk for or with early-stage
accelerated KOA and help identify prevention strategies.
The current findings supported previous observations
that there is an association between degenerative cruci-
ate ligaments and symptomatic KOA within the OAI
[13]. However, our results expanded on those findings
by demonstrating that cruciate ligament degeneration
was more associated with incident accelerated KOA than
a gradual onset of KOA. The cruciate ligament degener-
ation, which is characterized by altered fiber arrange-
ment and collagen composition, may compromise
ligamentous function and lead to instability and altered
joint loading [5, 14]. In fact, a degenerative cruciate
ligament may have similar consequences to a joint as a
complete tear. For example, individuals with ACL degen-
eration and individuals with an ACL rupture presented
with a greater severity of structural pathology (e.g.,
Table 2 Frequency of Degenerative Ligaments/Tendons
Among Accelerated Knee Osteoarthritis (AKOA), Common Knee
Osteoarthritis (KOA), No KOA
Frequency (n [%]) Visit AKOA Typical KOA No KOA
Cruciate Ligaments -2 39 (43) 14 (22) 25 (26)
(Anterior & Posterior) −1 50 (43) 34 (28) 30 (24)
Index 49 (47) 35 (28) 30 (24)
1 41 (51) 33 (31) 25 (26)
2 17 (47) 27 (33) 11 (21)
Anterior Cruciate
Ligamenta
−2 36 (40) 14 (22) 23 (24)
−1 44 (38) 32 (26) 27 (22)
Index 44 (42) 33 (27) 27 (22)
1 35 (44) 31 (28) 22 (23)
2 15 (42) 24 (29) 9 (17)
Posterior Cruciate
Ligamenta
−2 9 (10) 1 (2) 5 (5)
−1 14 (12) 8 (6) 6 (5)
Index 13 (12) 8 (6) 6 (5)
1 12 (15) 7 (6) 6 (6)
2 6 (17) 8 (10) 3 (6)
Collateral Ligaments −2 22 (24) 6 (9) 12 (13)
(Medial & Lateral) −1 28 (24) 19 (15) 17 (14)
Index 28 (26) 19 (15) 17 (14)
1 24 (30) 20 (18) 15 (15)
2 8 (22) 17 (20) 8 (15)
Medial Collateral
Ligamenta
−2 19 (21) 5 (8) 11 (11)
−1 24 (11) 16 (13) 16 (13)
Index 24 (23) 16 (13) 16 (13)
1 23 (29) 17 (15) 14 (14)
2 8 (22) 14 (17) 8 (15)
Lateral Collateral
Ligamenta
−2 5 (5) 3 (5) 3 (3)
−1 7 (6) 6 (5) 3 (2)
Index 7 (7) 6 (5) 3 (2)
1 4 (5) 6 (5) 2 (2)
2 2 (6) 6 (7) 0 (0)
Extensor Mechanism −2 40 (43) 26 (40) 21 (22)
−1 50 (43) 48 (39) 30 (24)
Index 47 (45) 51 (41) 32 (26)
1 36 (46) 46 (42) 26 (27)
2 11 (31) 33 (39) 17 (32)
Proximal Gastrocnemius
Tendon
−2 46 (50) 25 (38) 39 (41)
−1 54 (46) 54 (44) 51 (41)
Index 50 (47) 56 (45) 51 (41)
1 37 (46) 50 (45) 41 (42)
2 15 (42) 40 (48) 20 (38)
aThe sum of the prevalence for each specific ligaments will not equal the
overall cruciate or collateral ligament prevalence because some knees had
anterior and posterior cruciate ligament degeneration or medial and lateral
collateral ligament degeneration
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cartilage damage, bone marrow lesions) when compared
to individuals with a normal ACL; however, there were
no differences in these pathologies between adults with
degenerative or acute ACL pathology [7]. These struc-
tural changes may be attributable to rotational and
antero-posterior instability and increased external ad-
duction moments that occur during walking [15, 16].
These biomechanical changes may increase shear forces
and medial compartment loading, which could contrib-
ute to accelerated KOA [15, 16]. The degenerative cruci-
ate ligaments among those with accelerated KOA may
indicate that this rotational or anteroposterior instability
stresses the knee prior to the onset of disease. Addition-
ally, cruciate ligament degeneration may also place an
individual at greater risk for a knee injury, which may
compound the risk of developing accelerated KOA [13].
Adults with accelerated KOA may be distinct from those
with typical KOA and warrant greater consideration in
both clinical and research settings [2, 17–20]. Early de-
tection of cruciate ligament degeneration may help clini-
cians and researchers identify people at risk for or with
early-stage accelerated KOA and enable them to imple-
ment biomechanical interventions (e.g., gait retraining,
bracing) or exercise programs that reduce the risk of in-
jury or falls (e.g. neuromuscular training).
The role of a degenerative extensor mechanism in
KOA has been less studied and the significance of it
among those with accelerated or typical KOA should be
further explored. While multiple structures can help
distribute the load during knee flexion (e.g., proximal
gastrocnemius tendons), the extensor mechanism is the
sole mechanism for knee extension. Therefore, more
direct loading to the extensor may contribute to the
development of KOA; however, the cause and clinical
implications of extensor mechanism degeneration (e.g.,
implications for strength testing and therapeutic exer-
cises) warrants further study.
While this study characterized which ligamentous and
tendinous structures antedated the onset of accelerated
KOA, we acknowledge important limitations. For ex-
ample, our inter-reader agreement for detecting the
presence of degenerative signal changes in the ligaments
and tendons ranged from moderate to good. If we had a
stronger level of inter-reader agreement, we may have
observed stronger associations between these pathologic
findings and accelerated or typical KOA. Despite our
inter-reader agreement, we observed significant associa-
tions between degenerative extensor mechanisms and
cruciate ligaments with accelerated KOA. We also had
missing MR data that could effect the results, particu-
larly 2 years after the index visit. However, we performed
robust analyses that adjusted for variables related to
missing MR data. We also performed several sensitivity
analyses to explore the robustness of these findings. Our
study was also limited by the number of adults in each
group. Despite this, the OAI offered an extraordinary
chance to study the natural history of accelerated KOA.
Conclusions
Starting as early as 2 years prior to radiographic onset of
disease, adults with incident KOA were twice as likely to
have a degenerative extensor mechanism. Furthermore,
adults with accelerated KOA were more likely to have
degenerative cruciate ligaments, which could be the re-
sult of excessive overloading or contribute altered joint
mechanics that may increase the chance of accelerated
KOA. Identifying people with these degenerative struc-
tures using MR imaging prior to the onset of KOA may
help us target prevention strategies to help ameliorate
the risk of KOA, especially accelerated KOA.
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